Reaction
Tracheobronchitis reporting signals
As of the last recalculation, Tracheobronchitis appears in 763 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 43.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Voriconazole Injection | 33 | 43.3 | 43.4 |
| Micafungin Sodium | 12 | 39.2 | 39.3 |
| Ganciclovir | 13 | 35.2 | 35.3 |
| Sirolimus | 17 | 35.2 | 35.2 |
| Piperacillin And Tazobactam | 16 | 34.8 | 34.9 |
| Ganciclovir Sodium | 13 | 34.1 | 34.1 |
| Voriconazole | 33 | 30.9 | 31.0 |
| Piperacillin Sodium And Tazobactam Sodium | 18 | 25.6 | 25.6 |
| Meropenem | 29 | 25.6 | 25.6 |
| Amphotericin B | 11 | 24.3 | 24.3 |
| Oseltamivir | 7 | 24.2 | 24.2 |
| Trazodone Hydrochloride | 13 | 23.0 | 23.1 |
| Cefepime | 11 | 21.2 | 21.2 |
| Piperacillin Sodium,Tazobactam Sodium | 19 | 20.0 | 20.0 |
| Cefepime Hydrochloride | 11 | 18.9 | 18.9 |
| Ceftriaxone | 21 | 17.9 | 17.9 |
| Ceftriaxone Sodium | 24 | 17.6 | 17.6 |
| Ifosfamide | 13 | 16.8 | 16.8 |
| Ivacaftor | 3 | 10.3 | 10.3 |
| Remdesivir | 5 | 10.3 | 10.3 |
| Lumacaftor And Ivacaftor | 3 | 9.6 | 9.6 |
| Dornase Alfa | 6 | 8.4 | 8.4 |